Abstract:Triptolide is the major active component of Tripterygium wilfordii Hook. f., which has been used as an anti-inflammatory agent in traditional Chinese medicine for centuries. The mechanisms of the anti-inflammatory effects of triptolide in renal diseases are not well understood. Recent studies have shown that overexpression of monocyte chemoattractant protein-1 in renal tubular epithelial cells is associated with the inflammatory injuries of renal tubulointerstitium. In this study, we investigated the effect of triptolide on the overexpression of monocyte chemoattractant protein-1 in renal tubular epithelial cells in vitro. Human proximal tubular epithelial cells were treated with gamma interferon (200 μg/L) and tumor necrosis factor-alpha (20 μg/L) or combined with different concentrates of triptolide (0.4, 2, 10 μg/L) for 12 hours (for monocyte chemoattractant protein-1 mRNA measuring) or 24 hours (for monocyte chemoattractant protein-1 protein measuring). The expression of monocyte chemoattractant protein-1 mRNA was detected by using reverse transcriptase-polymerase chain reaction. The expression of monocyte chemoattractant protein-1 protein in the cells was measured by using flow cytometry. Monocyte chemoattractant protein-1 levels in the supernatant were measured by using the enzyme-linked immunosorbent assay method. After treatment with interferon-γ and tumor necrosis factor-α, monocyte chemoattractant protein-1 mRNA and protein levels in human proximal tubular epithelial cells and monocyte chemoattractant protein-1 concentrations in the supernatant were significantly increased. Triptolide (10 μg/L) can significantly inhibit the overexpression of monocyte chemoattractant protein-1 mRNA and protein in human proximal tubular epithelial cells. The increase of monocyte chemoattractant protein-1 protein in the supernatant was also markedly inhibited by triptolide (2, 10 μg/L). The results of this study suggest that the inhibition of monocyte chemoattractant protein-1 overexpression in tubular epithelial cells may contribute to the anti-inflammatory effects of triptolide in renal diseases.

Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage.

Modulatory Effect of Triptolide on Differentiation of Human Th17 Cells

Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways

Triptolide affects the differentiation, maturation and function of human dendritic cells.

Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice.

Anti-inflammatory and neuroprotective effects of Triptolide via the NF-κB signaling pathway in a rat MCAO model.

The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages

Triptolide induces PANoptosis in macrophages and causes organ injury in mice

Triptolide Inhibits TNF-α, IL-1β and NO Production in Primary Microglial Cultures

Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis

Triptolide Inhibits IL-12/IL-23 Expression in APCs via CCAAT/Enhancer-Binding Protein α

[Tripotolide Ameliorates Inflammation and Apoptosis Induced by Focal Cerebral Ischemia/reperfusion in Rats].

MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages

Triptolide is a Potent Suppressant of C3, CD40 and B7h Expression in Activated Human Proximal Tubular Epithelial Cells

Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis

The suppressive effect of triptolide on chronic colitis and TNF-α/TNFR2 signal pathway in interleukin-10 deficient mice

Triptolide Inhibits Osteoclast Differentiation and Bone Resorption In Vitro via Enhancing the Production of IL-10 and TGF-β1 by Regulatory T Cells.

Triptolide suppresses IL-1β-induced chemokine and stromelysin-1 gene expression in human colonic subepithelial myofibroblasts

Triptolide suppresses IL-1beta-induced chemokine and stromelysin-1 gene expression in human colonic subepithelial myofibroblasts

Triptolide Down‐regulates COX‐2 Expression and PGE2 Release by Suppressing the Activity of NF‐κB and MAP Kinases in Lipopolysaccharide‐treated PC12 Cells

Triptolide Down-Regulates Tumor Necrosis Factor-Α and Interferon-Γ-induced Overexpression of Monocyte Chemoattractant Protein-1 in Human Proximal Tubular Epithelial Cells